Adhera Therapeutics, Inc. (32)
Browse by Contract Category
Contracts
-
Form of Warrant
(Filed With SEC on October 13, 2021)
-
License Agreement
(Filed With SEC on August 4, 2021)
-
Consulting Agreement between Company and Andrew Kucharchuk
(Filed With SEC on July 13, 2020)
-
Description of Securities
(Filed With SEC on April 14, 2020)
-
Settlement Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Robert R. Moscato, Jr
(Filed With SEC on April 5, 2019)
-
Form of 10% Convertible Redeemable Note
(Filed With SEC on October 13, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on October 13, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on August 24, 2021)
-
Form of Warrant
(Filed With SEC on August 24, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on August 24, 2021)
-
Form of Common Stock Purchase Warrants issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021
(Filed With SEC on August 23, 2021)
-
Form of Convertible Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021
(Filed With SEC on August 23, 2021)
-
Form of Warrant
(Filed With SEC on August 18, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on August 18, 2021)
-
Form of Warrant
(Filed With SEC on April 23, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on April 23, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on February 9, 2021)
-
Form of Warrant
(Filed With SEC on February 9, 2021)
-
Form of Warrant
(Filed With SEC on November 5, 2020)
-
Form of Senior Secured Convertible Note
(Filed With SEC on November 5, 2020)
-
Security Agreement dated June 26, 2020
(Filed With SEC on June 30, 2020)
-
Form of Convertible Promissory Note
(Filed With SEC on June 30, 2020)
-
Securities Purchase Agreement dated as of February 5, 2020 between Adhera Therapeutics, Inc. and the purchasers identified on the signature pages thereto
(Filed With SEC on February 11, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on February 11, 2020)
-
Form of Convertible Promissory Note
(Filed With SEC on February 11, 2020)
-
Employment Agreement, dated as of October 29, 2019, by and between Adhera Therapeutics, Inc. and Rhonda Stanley
(Filed With SEC on November 4, 2019)
-
Form of Subscription Agreement
(Filed With SEC on August 7, 2019)
-
Security Agreement, dated as of June 28, 2019, among Adhera Therapeutics, Inc., IThenaPharma, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., the purchasers of secured...
(Filed With SEC on July 3, 2019)
-
Form of Secured Promissory Note
(Filed With SEC on July 3, 2019)
-
2018 Long-Term Incentive Plan of the Registrant
(Filed With SEC on April 16, 2019)
-
Form of Subscription Agreement used in connection with the offering of the Series F Convertible Preferred Stock of the Registrant
(Filed With SEC on April 16, 2019)
-
Employment Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Nancy R. Phelan
(Filed With SEC on April 5, 2019)
